In September of 2000, the world's leading experts in MC met to discuss and present data at the "Year 2000 Working Conference on Mastocytosis," held in Vienna, Austria. Table 1 presents a uniform ...

Mastocytosis is a rare disorder that develops when the immune system overproduces mast cells—a type of white blood cell that plays an important role in your body's inflammatory process and helps fight ...

Cogent Biosciences' uncertain competitive edge may compel investors to sit on the sidelines. Read more about the cautious ...

A standard treatment for mastocytosis is difficult to apply to individual patients based on the variable clinical course. A general consensus for using antimediator agents such as antihistamines ...

The following is a summary of "Comparison of prognostic scores according to WHO classification in 170 patients with advanced ...

Blueprint Medicines' AYVAKIT continues to gain traction among key stakeholders. See more on BPMC stock and the factors ...

After months of unanswered questions, Laura was finally told that her 17-month-old had mastocytosis - a rare condition caused by an excess number of mast cells gathering in the body's tissues.

Opens in a new tab or window An analysis of registry data concluded that hypersensitivity reactions in patients with mastocytosis are caused by exposure to certain triggers, including low tryptase ...

Sudipto Mukherjee, MD, PhD, MPH, of Cleveland Clinic, describes the steps clinicians should take when they encounter clinical abnormalities that may point to systemic mastocytosis. (1:48 ...

The following is a summary of “Clustering of clinical symptoms using large language models reveals low diagnostic specificity of proposed alternatives to consensus mast cell activation syndrome ...

Allakos (ALLK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jonathan ...